Publications by authors named "H Warburton"
Article Synopsis
- This text discusses the role of social prescribing in connecting older people from ethnic minority groups to cultural offerings that can help address issues like loneliness and poor mental health.
- A scoping review was conducted to analyze existing literature on how cultural activities are tailored for these older populations in the UK, resulting in six key sources that highlight both opportunities and barriers to engagement.
- The findings suggest that consulting with the target groups is crucial for creating inclusive activities and emphasize the need for more research in this area, as cultural providers currently lack sufficient evidence to effectively develop their offerings.
Knowledge of ecosystem-size influences on river populations and communities is integral to the balancing of human and environmental needs for water. The multiple dimensions of dendritic river networks complicate understanding of ecosystem-size influences, but could be resolved by the development of scaling relationships. We highlight the importance of physical constraints limiting predator body sizes, movements, and population sizes in small rivers, and where river contraction limits space or creates stressful conditions affecting community stability and food webs.
View Article and Find Full Text PDFSocial prescribing is a non-clinical approach to addressing social, environmental, and economic factors affecting how people feel physical and/or emotionally. It involves connecting people to "community assets" (e.g.
View Article and Find Full Text PDFBackground: Non-medical issues (e.g. loneliness, financial concerns, housing problems) can shape how people feel physically and psychologically.
View Article and Find Full Text PDFAdjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
Eur Urol
June 2023
Background: Adjuvant intravesical chemotherapy following tumour resection is recommended for intermediate-risk non-muscle-invasive bladder cancer (NMIBC).
Objective: To assess the efficacy and safety of adjuvant intravesical chemohyperthermia (CHT) for intermediate-risk NMIBC.
Design, Setting, And Participants: HIVEC-II is an open-label, phase 2 randomised controlled trial of CHT versus chemotherapy alone in patients with intermediate-risk NMIBC recruited at 15 centres between May 2014 and December 2017 (ISRCTN 23639415).